Definition
Processes by which drugs are discovered and designed with analytical techniques such as NMR.
Introduction
Drug discovery is an ongoing and challenging process that is fraught with failure, but the successes have had profound impacts on human health. Fundamentally, drug discovery is a multidisciplinary endeavor requiring, among others, bioinformatics and computational chemistry, cell biology, medicinal chemistry, enzymology, high-throughput screening (HTS), molecular biology, protein chemistry, genomics and other “omics” technologies, and structural biology. Drug discovery is also an iterative procedure comprising four stages: target identification and validation, lead discovery, lead optimization, and clinical trials (Betz et al. 2006). In general, the drug discovery process starts by identifying a protein target associated with drug resistance, the progression or pathology of a disease, or the...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Betz M, Saxena K, et al. Biomolecular NMR: a chaperone to drug discovery. Curr Opin Chem Biol. 2006;10(3):219–25.
Bohacek RS, McMartin C, et al. The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev. 1996;16(1):3–50.
Bylesjo M, Rantalainen M, et al. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom. 2006;20(8–10):341–51.
Fejzo J, Lepre CA, et al. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol. 1999;6(10):755–69.
Hadjduk J, Greer J. A decade of fragment-based drug design: stratigeic advances and leassons learned. Nat Rev Drug Discov. 2007;6:211–19.
Halouska S, Fenton RJ, et al. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol. 2012;7(1):166–71.
Heller M, Kessler H. NMR spectroscopy in drug design. Pure Appl Chem. 2001;73(9):1429–36.
Kanelis V, Forman-Kay JD, et al. Multidimensional NMR methods for protein structure determination. IUBMB Life. 2001;52(6):291–302.
Lewis IA, Schommer SC, et al. Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. Anal Chem. 2007;79(24):9385–90.
Light DW, Warburton R. Demythologizing the high costs of pharmaceutical research. Biosocieties. 2011;6(1):34–50.
Lipinski C. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–41.
Pellecchia M, Sem DS, et al. NMR in drug discovery. Nat Rev Drug Discov. 2002;1(3):211–9.
Pellecchia M, Bertini I, et al. Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov. 2008;7(9):738–45.
Powers R. NMR metabolomics and drug discovery. Magn Reson Chem MRC. 2009;47(Suppl 1):S2–11.
Powers R, Mercier KA, et al. The application of FAST-NMR for the identification of novel drug discovery targets. Drug Discov Today. 2008;13(3–4):172–9.
Roberts GCK. Applications of NMR in drug discovery. Drug Discov Today. 2000;5(6):230–40.
Shortridge MD, Hage DS, et al. Estimating protein-ligand binding affinity using high-throughput screening by NMR. J Comb Chem. 2008;10(6):948–58.
Stark JL, Mercier KA, et al. Solution structure and function of YndB, an AHSA1 protein from Bacillus subtilis. Proteins. 2010;78(16):3328–40.
Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. III. A generalized procedure for determination of lineshape variations. J Magn Reson. 2002;154(2):163–75.
Widmer H, Jahnke W. Protein NMR in biomedical research. Cell Mol Life Sci CMLS. 2004;61(5):580–99.
Zartler ER, Shapiro MJ. Fragonomics: fragment-based drug discovery. Curr Opin Chem Biol. 2005;9(4):366–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 European Biophysical Societies' Association (EBSA)
About this entry
Cite this entry
Halouska, S., Powers, R. (2013). NMR in Drug Discovery – Introduction. In: Roberts, G.C.K. (eds) Encyclopedia of Biophysics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16712-6_305
Download citation
DOI: https://doi.org/10.1007/978-3-642-16712-6_305
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16711-9
Online ISBN: 978-3-642-16712-6
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences